Cargando…
AGGF1 therapy inhibits thoracic aortic aneurysms by enhancing integrin α7-mediated inhibition of TGF-β1 maturation and ERK1/2 signaling
Thoracic aortic aneurysm (TAA) is a localized or diffuse dilatation of the thoracic aortas, and causes many sudden deaths each year worldwide. However, there is no effective pharmacologic therapy. Here, we show that AGGF1 effectively blocks TAA-associated arterial inflammation and remodeling in thre...
Autores principales: | Da, Xingwen, Li, Ziyan, Huang, Xiaofan, He, Zuhan, Yu, Yubing, Tian, Tongtong, Xu, Chengqi, Yao, Yufeng, Wang, Qing K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119315/ https://www.ncbi.nlm.nih.gov/pubmed/37081014 http://dx.doi.org/10.1038/s41467-023-37809-x |
Ejemplares similares
-
Protein therapy of skeletal muscle atrophy and mechanism by angiogenic factor AGGF1
por: He, Zuhan, et al.
Publicado: (2023) -
Angiogenic factor AGGF1 blocks neointimal formation after vascular injury via interaction with integrin α7 on vascular smooth muscle cells
por: Yu, Yubing, et al.
Publicado: (2022) -
Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury
por: Yao, Yufeng, et al.
Publicado: (2017) -
Angiogenic Factor AGGF1 Activates Autophagy with an Essential Role in Therapeutic Angiogenesis for Heart Disease
por: Lu, Qiulun, et al.
Publicado: (2016) -
Angiogenic Factor AGGF1 Promotes Therapeutic Angiogenesis in a Mouse Limb Ischemia Model
por: Lu, Qiulun, et al.
Publicado: (2012)